Viral genotypes and p53 expression in Epstein-Barr virus-associated primary malignant lymphomas of the intestines

Human Pathology

Volumn 30, Issue 10, 1999, Pages 1146-1152

  Kim, Young Sik ^a   Kim, Jung Bun ^b   Kang, Yong Koo ^b   Nam, Eun Sook ^b   Park, Seol Hee ^b   Kim, Insun ^b  

^a Korea University College of Medicine   (South Korea)

^b NONE

Author keywords

Epstein Barr virus; Genotype; Intestine; Malignant lymphoma; P53

Indexed keywords

PROTEIN P53; VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; GENOTYPE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTESTINE LYMPHOMA; INTESTINE TUMOR; NONHUMAN; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; VIRUS DETECTION; VIRUS INFECTION;

EID: 13044313484     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90030-8     Document Type: Article

References (44)

1. Epstein MA, Achong BG, Barr YM: Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1:702-705, 1964
2. Wu T-C, Mann RB, Epstein J: Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma: A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am J Pathol 138:1461-1469, 1991
3. Weiss LM, Movahed LA, Warnke RA: Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 320:502-506, 1989
4. Katz BZ, Raab-Taub N, Miller G: Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. J Infect Dis 160:589-597, 1989
5. Butler A, Colby TV, Weiss L, et al: Lymphoepithelioma-like carcinoma of the lung. Am J Surg Pathol 13:632-639, 1989
6. Lee SS, Jang JJ, Cho KJ, et al: Epstein-Barr virus-associated primary gastrointestinal lymphoma in non-immunocompromised patients in Korea. Histopathology 3:234-242, 1997
7. Yang WI, Cho MS, Tomita Y, et al: Epstein-Barr virus and gastrointestinal lymphomas in Korea. Yonsei Med J 39:268-276, 1998
8. Spruck CH, Tsai YC, Huang DP, et al: Absence of p53 gene mutations in primary nasopharyngeal carcinomas. Cancer Res 52:4787-4790, 1992
9. Chang YS, Lin YJ, Tsai CN, et al: Detection of mutations in the p53 gene in human head and neck carcinomas by single strand conformation polymorphism analysis. Cancer Lett 67:167-174, 1992
10. Niedobitek G, Rowlands DC, Young LS, et al: Overexpression of p53 in Hodgkin's disease: Lack of correlation with EBV infection. J Pathol 169:207-212, 1993
11. Lee JH, Lee SS, Park JS, et al: Altered p53 expression in Epstein Barr virus positive T cell lymphomas. J Korean Med Sci 10:399-405, 1995
12. Gulley ML, Burton MP, Allred DC, et al: Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinoma. HUM PATHOL 29:252-259, 1998
13. Gulley ML, Pulitzer DR, Eagan PA, et al: Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation. HUM PATHOL 27:20-27, 1996
14. Elenitoba-Johnson KS, Medeiros LJ, Khorsand J, et al: p53 expression in Reed-Sternberg cells does not correlate with gene mutations in Hodgkin's disease. Am J Clin Pathol 106:728-738, 1996
15. Chen WG, Chen YY, Kamel OW, et al: p53 mutations in Hodgkin's disease. Lab Invest 75:519-527, 1996
16. Chilosi M, Doglioni C, Menestrina F, et al: Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease. Blood 84:4295-4300, 1994
17. Lavigueur A, Maltby V, Mock D, et al: High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cell Biol 9:3982-3991, 1989
18. Chen W, Cooper NR: Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-kappa B activity. J Virol 70:4849-4853, 1996
19. Szekely L, Selivanova G, Magnusson KP, et al: EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci U S A 90:5455-5459, 1993
20. Adldinger HK, Delius H, Freese UK, et al: A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes. Virology 141:221-234, 1985
21. Zimber U, Adldinger HK, Lenoir GM, et al: Geographical prevalence of two types of Epstein-Barr virus. Virology 154:56-66, 1986
22. Rickinson AB, Young LS, Rowe M: Influence of the Epstein-Barr virus nuclear antigen EBNA-2 on the growth phenotype of virus-transformed B cells. J Virol 61:1310-1317, 1987
23. Kim YS, Paik SR, Kim HK, et al: Epstein-Barr virus and CD21 expression in gastrointestinal tumors. Pathol Res Pract 194:705-711, 1998
24. Lavergne A, Brocheriou I, Delfau MH, et al: Primary intestinal gamma-delta T-cell lymphoma with evidence of Epstein-Barr virus. Histopathology 32:271-276, 1998
25. Anagnostopoulos I, Hummel M, Stein H: Frequent presence of latent Epstein-Barr virus infection in peripheral T-cell lymphomas: A review. Leukoc Lymph 19:1-12, 1995
26. Zhou XG, Hamilton-Duboit SJ, Yan QH, et al: High frequency of Epstein-Barr virus in Chinese peripheral T-cell lymphoma. Histopathology 24:115-122, 1994
27. Borisch B, Hennig I, Horber F, et al: Enteropathy-associated T-cell lymphoma in a renal transplant patient with evidence of Epstein-Barr virus involvement. Virchows Arch 421:443-447, 1992
28. Chen WG, Chen YY, Bacchi MM, et al: Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue: Type A with a high prevalence of deletions within the latent membrane protein gene. Am J Pathol 148:17-23, 1996
29. Young LS, Yao QY, Roponey CM, et al: New type B isolate of Epstein-Barr virus from Burkitt's lymphoma and normal individuals in endemic areas. J Gen Virol 68:2853-2862, 1987
30. Sculley TB, Apollini A, Hurren L, et al: Coinfection with A-and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects. J Infect Dis 162:643-648, 1990
31. Kyaw MT, Hurren L, Evans L, et al: Expression of B-type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipients. AIDS Res 8:1869-1874, 1992
32. Shibata D, Weiss LM, Hernandez AM, et al: Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood 81:2102-2109, 1993
33. Boyle MJ, Sewell WA, Sculley TB, et al: Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin's lymphoma. Blood 78:3004-3011, 1991
34. Borisch B, Finke J, Henning I, et al: Distribution and localization of Epstein-Barr virus subtypes A and B in AIDS-related lymphomas and lymphatic tissue of HIV-positive patients. J Pathol 168:229-236, 1992
35. Momad J, Zambetti GP, Olson DC, et al: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245, 1992
36. Oliner JD, Pietenpol JA, Thiagalingam S, et al: Oncoprotein mdm2 conceals the activation domain of tumor suppressor p53. Nature 362:857-860, 1993
37. Shen Y, Shenk T: Relief of p53-mediated transcriptional repression by the adenovirus E1B 19 kDa protein or the cellular Bcl-2 protein. Proc Natl Acad Sci U S A 91:8940-8944, 1994
38. Havre PA, Yuan J, Hedrick L, et al: p53 inactivation by HPV 16 E6 results in increased mutagenesis in human cells. Cancer Res 55:4420-4424, 1995
39. Lane DP, Crawford LV: T antigen is bound to a host protein in SV40-transformed cells. Nature 278:261-263, 1979
40. Stuart ET, Haffner R, Oren M, et al: Loss of p53 function through PAX-mediated transcriptional repression. EMBOJ 14:5638-5645, 1995
41. Moll UM, Riou G, Levine AJ: Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci U S A 89:7262-7266, 1992
42. Hayashi K: PCR-SSCP: A method for detection of mutations. Genet Anal Tech App 19(3):73-79, 1992
43. Reich NC, Levine AJ: Growth regulation of a cellular tumour antigen, p53, in nontransformed cells. Nature 308:199-201, 1984
44. Rickinson AB: EBV infection and EBV-associated tumor, in Mison AC, Neil JC, McRae MA, et al (eds): Viruses and Cancer. Cambridge, United Kingdom, Cambridge University Press, 1994, pp 81-100